Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Brumpt

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|May 11, 1990
[Uncomplicated lower urinary tract infection in women: new therapeutics]I Brumpt
La Revue Du Praticien|May 11, 1979
[Non-typhoid salmonellosis]G Charmot, I Brumpt
Drugs|January 1, 1995
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studiesG G Grassi, I Brumpt
Revue De Pneumologie Clinique|February 3, 2005
[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors]P Zuck, P Veyssier, I Brumpt
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety GroupP Jaillon, J Morganroth, I Brumpt, et al.
La Nouvelle Presse Medicale|December 26, 1981
[Fatal complications of a single infusion of mithramycin]I Brumpt, A Baglin, R Alterescu, et al.
Journal of Medical Virology|January 1, 1978
Biological activity of hepatitis B antigens in cell cultureI Brumpt, G F Mann, A J Zuckerman
Therapie|November 1, 1982
[Febrile attacks, isolated and repeated caused by glafenine]I Brumpt, B Rouveix, D Salmon, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose]J Guibert, M D Kitzis, I Brumpt, et al.
La Nouvelle Presse Medicale|February 24, 1979
[Transmission of plasmodium falciparum malaria by syringe in a patient with heroinism]R Bastin, G Charmot, I Brumpt, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|May 11, 1990
[Uncomplicated lower urinary tract infection in women: new therapeutics]I Brumpt
La Revue Du Praticien|May 11, 1979
[Non-typhoid salmonellosis]G Charmot, I Brumpt
Drugs|January 1, 1995
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studiesG G Grassi, I Brumpt
Revue De Pneumologie Clinique|February 3, 2005
[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors]P Zuck, P Veyssier, I Brumpt
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety GroupP Jaillon, J Morganroth, I Brumpt, et al.
La Nouvelle Presse Medicale|December 26, 1981
[Fatal complications of a single infusion of mithramycin]I Brumpt, A Baglin, R Alterescu, et al.
Journal of Medical Virology|January 1, 1978
Biological activity of hepatitis B antigens in cell cultureI Brumpt, G F Mann, A J Zuckerman
Therapie|November 1, 1982
[Febrile attacks, isolated and repeated caused by glafenine]I Brumpt, B Rouveix, D Salmon, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose]J Guibert, M D Kitzis, I Brumpt, et al.
La Nouvelle Presse Medicale|February 24, 1979
[Transmission of plasmodium falciparum malaria by syringe in a patient with heroinism]R Bastin, G Charmot, I Brumpt, et al.
Pageof 2